The Rise of Expanded Hemodialysis

Blood Purification

Volumn 44, Issue 2, 2017, Pages I-VIII

  Ronco, Claudio ^a,b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; HEPCIDIN; OSTEOPROTEGERIN;

AMYLOIDOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DIALYSIS MEMBRANE; END STAGE RENAL DISEASE; ERYTHROPOIESIS; HEMODIAFILTRATION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MEMBRANE PERMEABILITY; MICROFLUIDICS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RHABDOMYOLYSIS; SEPSIS; THROMBOGENICITY; ULTRAFILTRATION; UREMIA; VASCULAR ACCESS; ARTIFICIAL MEMBRANE; DEVICES; EQUIPMENT DESIGN; INVENTION; PERMEABILITY; PROCEDURES;

EQUIPMENT DESIGN; HUMANS; INVENTIONS; MEMBRANES, ARTIFICIAL; PERMEABILITY; RENAL DIALYSIS; UREMIA;

EID: 85019053586     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000476012     Document Type: Review

References (33)

1. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
2. Neirynck N, Vanholder R, Schepers E, Eloot S, Pletinck A, Glorieux G: An update on uremic toxins. Int Urol Nephrol 2013; 45: 139-150.
3. Miyata T, Jadoul M, Kurokawa K, Van Ypersele de Strihou C: Beta-2 microglobulin in renal disease. J Am Soc Nephrol 1998; 9: 1723-1735.
4. Cianciolo G, Colí L, La Manna G, Donati G, D'Addio F, Comai G, Ricci D, Dormi A, Wratten M, Feliciangeli G, Stefoni S: Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach. Int J Artif Organs 2007; 30: 864-878.
5. Cianciolo G, La Manna G, Colì L, Donati G, D'Addio F, Persici E, Comai G, Wratten M, Dormi A, Mantovani V, Grossi G, Stefoni S: 5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients. Am J Nephrol 2008; 28: 941-948.
6. Desjardins L, Liabeuf S, Lenglet A, Lemke HD, Vanholder R, Choukroun G, Massy ZA; European Uremic Toxin (EUTox) Work Group: Association between free light chain levels, and disease progression and mortality in chronic kidney disease. Toxins (Basel) 2013; 5: 2058-2073.
7. Bonello M, Levin NW, Ronco C: History and evolution of the vascular access for hemodialysis. Contrib Nephrol 2004; 142: 1-13.
8. Ronco C, Brendolan A, Bragantini L, Chiaramonte S, Fabris A, Feriani M, Dell'Aquila R, Milan M, Scabardi M, Pinna V, La Greca G: Technical and clinical evaluation of different short, highly efficient dialysis techniques. Contr Nephrol 1988; 61: 46-68.
9. Collins A, Ilstrup K, Hanson G, Berkseth R, Keshaviah P: Rapid high-efficiency hemodialysis. Artif Organs 1986; 10: 185-188.
10. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534.
11. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfsen M, Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978;14:491-500.
12. Babb AL, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meterhour hypothesis. Trans Am Soc Artif Intern Organs 1971; 17: 81-91.
13. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996; 50: 1293-1302.
14. Locatelli F, Gauly A, Czekalski S, Hannedouche T, Jacobson SH, Loureiro A, Martin-Malo A, Papadimitriou M, Passlick-Deetjen J, Ronco C, Vanholder R, Wizemann V; Membrane Permeability Outcome (MPO) Study Group: The MPO Study: just a European HEMO Study or something very different? Blood Purif 2008; 26: 100-104.
15. Ronco C: Hemodiafiltration: evolution of a technique towards better dialysis care. Contrib Nephrol 2011; 168: 19-27.
16. Ronco C: Hemodiafiltration: technical and clinical issues. Blood Purif 2015; 40(suppl 1): 2-11.
17. Barreto FC, Stinghen AE, de Oliveira RB, Franco AT, Moreno AN, Barreto DV, Pecoits-Filho R, Drüeke TB, Massy ZA: The quest for a better understanding of chr onic kidney disease complications: an update on uremic toxins. J Bras Nefrol 2014; 36: 221-235.
18. Zickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, Hulko M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Fiedler R, Girndt M: Medium cut-off (MCO) membranes reduce inflammation in chronic dialysis patients-a randomized controlled clinical trial. PLoS One 2017; 12:e0169024.
19. Ronco C, Crepaldi C, Brendolan A, Bragantini L, d'Intini V, Inguaggiato P, Bonello M, Krause B, Deppisch R, Goehl H, Scabardi A: Evolution of synthetic membranes for blood purification: the case of the Polyflux family. Nephrol Dial Transplant 2003; 18(suppl 7): vii10-vii20; discussion vii55.
20. Fiore GB, Guadagni G, Lupi A, Ricci Z, Ronco C: A new semiempirical mathematical model for prediction of internal filtration in hollow fiber hemodialyzers. Blood Purif 2006; 24: 555-568.
21. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A; ESHOL Study Group. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24: 487-497.
22. Ronco C: Hemodiafiltration: evolution of a technique towards better dialysis care. Contrib Nephrol 2011; 168: 19-27.
23. Fiore GB, Ronco C: Principles and practice of internal hemodiafiltration. Contrib Nephrol 2007; 158: 177-184.
24. Ronco C: Fluid mechanics and crossfiltration in hollow-fiber hemodialyzers. Contrib Nephrol 2007; 158: 34-49.
25. Ronco C, Brendolan A, Lupi A, Metry G, Levin N W: Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 2000; 58: 809-817.
26. Ronco C, Brendolan A, Feriani M, Milan M, Conz P, Lupi A, Berto P, Bettini M, La Greca G: A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int 1992; 41: 1383-1393.
27. Rangel AV, Kim JC, Kaushik M, Garzotto F, Neri M, Cruz DN, Ronco C: Backfiltration: past, present and future. Contrib Nephrol 2011; 175: 35-45.
28. Ward RA: Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J Am Soc Nephrol 2005; 16: 2421-2430.
29. Kirsch AH, Lyko R, Nilsson LG, Beck W, Amdahl M, Lechner P, Schneider A, Wanner C, Rosenkranz AR, Krieter DH: Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant 2017; 32: 165-172.
30. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B: Extended characterization of a new class of membranes for blood purification: the high cut-off membranes. Int J Artif Organs 2013; 36: 455-463.
31. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B: MCO membranes: enhanced selectivity in high-flux class. Sci Rep 2015; 5: 18448.
32. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736.
33. Ronco C, La Manna G: Expanded hemodialysis: a new therapy for a new class of membranes; in La Manna G, Ronco C (eds): Current Perspectives in Kidney Diseases. Basel, Contrib Nephrol, Karger, 2017, pp 124-133.